The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention
Open accessAbstract
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Kodera, Y., Takeyama, K.-I., Murayama, A., Suzawa, M., Masuhiro, Y., & Kato, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000517200 · Cited by 187
RetractedMantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Towards a knowledge-based Human Protein Atlas
Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt1210-1248 · Cited by 2,440
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Peroxisome proliferator-activated receptor a target genes
Mandard, S., M�ller, M., & Kersten, S. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3216-3 · Cited by 1,218
Regulation of Muscle Fiber Type and Running Endurance by PPARδ
Wang, Y.-X., Zhang, C.-L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., Ham, J., Kang, H., & Evans, R. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020294 · Cited by 1,089
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T.-C., Chan, T. A., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,085
Oliver, W. R., Shenk, J. L., Snaith, M. R., Russell, C. S., Plunket, K. D., Bodkin, N. L., Lewis, M. C., Winegar, D. A., Sznaidman, M. L., Lambert, M. H., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091021198 · Cited by 1,046
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Varga, T., Czimmerer, Z., & Nagy, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.014 · Cited by 933
TNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863
Self-citationHypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
Reddy, J. K., Azarnoff, D. L., & Hignite, C. E. (1980) · Nature · doi:10.1038/283397a0 · Cited by 837
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306981100 · Cited by 832
PPAR and human metabolic disease
Semple, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28003 · Cited by 827
Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration
Sansom, O. J., Reed, K. R., Hayes, A. J., Ireland, H., Brinkmann, H., Newton, I. P., Batlle, E., Simon-Assmann, P., Clevers, H., Nathke, I. S., et al. (2004) · Genes & Development · doi:10.1101/gad.287404 · Cited by 799
PAX8-PPAR γ 1 Fusion in Oncogene Human Thyroid Carcinoma
Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C.-J., Mueller, E., Spiegelman, B. M., & Fletcher, J. A. (2000) · Science · doi:10.1126/science.289.5483.1357 · Cited by 784
Wolin, K. Y., Carson, K., & Colditz, G. A. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0285 · Cited by 778
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
Tontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.237 · Cited by 653
Zhu, Y., Qi, C., Korenberg, J. R., Chen, X. N., Noya, D., Rao, M. S., & Reddy, J. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7921 · Cited by 653
Wnt/β-Catenin Is Essential for Intestinal Homeostasis and Maintenance of Intestinal Stem Cells
Fevr, T., Robine, S., Louvard, D., & Huelsken, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01034-07 · Cited by 649
Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells
Glass, C. K., & Saijo, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2748 · Cited by 619
Lefebvre, A.-M., Chen, I., Desreumaux, P., Najib, J., Fruchart, J.-C., Geboes, K., Briggs, M., Heyman, R., & Auwerx, J. (1998) · Nature Medicine · doi:10.1038/2036 · Cited by 611
Notterman, D. A., Alon, U., Sierk, A. J., & Levine, A. J. (2001) · PubMed · Cited by 606
Guerre-Millo, M., Gervois, P., Raspé, E., Madsen, L., Poulain, P., Derudas, B., Herbert, J.-M., Winegar, D. A., Willson, T. M., Fruchart, J.-C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16638 · Cited by 605
Activators of the nuclear receptor PPARγ enhance colon polyp formation
Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U, T. M., Baird, S. M., Thomazy, V. A., & Evans, R. M. (1998) · Nature Medicine · doi:10.1038/2042 · Cited by 587
Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms
Straus, D. S., & Glass, C. K. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.003 · Cited by 554
Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
Choi, J. H., Banks, A. S., Kamenecka, T. M., Busby, S. A., Chalmers, M. J., Kumar, N., Kuruvilla, D. S., Shin, Y., He, Y., Bruning, J. B., et al. (2011) · Nature · doi:10.1038/nature10383 · Cited by 536
Xin, X., Yang, S., Kowalski, J., & Gerritsen, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9116 · Cited by 513
Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
Schwartz, A. V., Sellmeyer, D. E., Vittinghoff, E., Palermo, L., Lecka-Czernik, B., Feingold, K. R., Strotmeyer, E. S., Resnick, H. E., Carbone, L., Beamer, B. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2226 · Cited by 500
Demetri, G. D., Fletcher, C. D. M., Mueller, E., Sarraf, P., Naujoks, R., Campbell, N., Spiegelman, B. M., & Singer, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3951 · Cited by 495
Peters, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2029 · Cited by 479
Self-citationRat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding
Escher, P., Braissant, O., Basu-Modak, S., Michalik, L., Wahli, W., & Desvergne, B. (2001) · Endocrinology · doi:10.1210/endo.142.10.8458 · Cited by 472
The Relationship Between Cyclooxygenase-2 Expression and Colorectal Cancer
Sheehan, K. M. (1999) · JAMA · doi:10.1001/jama.282.13.1254 · Cited by 461
Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.827 · Cited by 457
Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
Grommes, C., Landreth, G. E., & Heneka, M. T. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01509-8 · Cited by 440
Mueller, E., Smith, M., Sarraf, P., Kroll, T., Aiyer, A., Kaufman, D. S., Oh, W., Demetri, G., Figg, W. D., Zhou, X.-P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180329197 · Cited by 426
Bishop-Bailey, D., & Hla, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17042 · Cited by 424
Grey, A., Bolland, M., Gamble, G., Wattie, D., Horne, A., Davidson, J., & Reid, I. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2646 · Cited by 401
Gupta, R. A., Tan, J., Krause, W. F., Geraci, M. W., Willson, T. M., Dey, S. K., & DuBois, R. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13275 · Cited by 401
Critical roles of PPARβ/δ in keratinocyte response to inflammation
Tan, N. S., Michalik, L., Noy, N., Yasmin, R., Pacot, C., Heim, M., Flühmann, B., Desvergne, B., & Wahli, W. (2001) · Genes & Development · doi:10.1101/gad.207501 · Cited by 398
Peroxisome proliferator-activated receptor gamma and cancers.
Koeffler, H. P. (2003) · PubMed · Cited by 396
PPARα: Energy Combustion, Hypolipidemia, Inflammation and Cancer
Pyper, S. R., Viswakarma, N., Yu, S., & Reddy, J. K. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08002 · Cited by 379
Patel, L., Pass, I., Coxon, P., Downes, C. P., Smith, S. A., & Macphee, C. H. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00225-1 · Cited by 365
Osborne, C. K., Coronado-Heinsohn, E. B., Hilsenbeck, S. G., McCue, B. L., Wakeling, A. E., McCleland, R. A., Manning, D. L., & Nicholson, R. I. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.746 · Cited by 361
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
Fajas, L., Fruchart, J.-C., & Auwerx, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01273-3 · Cited by 336
Di-Poı̈, N., Tan, N. S., Michalik, L., Wahli, W., & Desvergne, B. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00646-9 · Cited by 327
Safety issues and prospects for future generations of PPAR modulators
RUBENSTRUNK, A., HANF, R., HUM, D., FRUCHART, J., & STAELS, B. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.003 · Cited by 309
Kim, Y., Suh, N., Sporn, M., & Reed, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202458200 · Cited by 309
Activation of PPARδ alters lipid metabolism in db/db mice
Leibowitz, M. D., Fiévet, C., Hennuyer, N., Peinado-Onsurbe, J., Duez, H., Berger, J., Cullinan, C. A., Sparrow, C. P., Baffic, J., Berger, G. D., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01554-4 · Cited by 308
Shi, Y., Hon, M., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052707099 · Cited by 303
Palakurthi, S. S., Aktaş, H., Grubissich, L., Mortensen, R. M., & Halperin, J. A. (2001) · PubMed · Cited by 302
Gupta, R. A., Wang, D., Katkuri, S., Wang, H., Dey, S. K., & DuBois, R. N. (2004) · Nature Medicine · doi:10.1038/nm993 · Cited by 275
Tanaka, T., Kohno, H., Yoshitani, S., Takashima, S., Okumura, A., Murakami, A., & Hosokawa, M. (2001) · PubMed · Cited by 270
Panigrahy, D., Kaipainen, A., Huang, S., Butterfield, C. E., Barnés, C. M., Fannon, M., Laforme, A. M., Chaponis, D. M., Folkman, J., & Kieran, M. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711281105 · Cited by 269
Shah, Y. M., Morimura, K., Yang, Q., Tanabe, T., Takagi, M., & Gonzalez, F. J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00317-07 · Cited by 255
Self-citationThe Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR)
Peraza, M. A., Burdick, A. D., Marin, H. E., Gonzalez, F. J., & Peters, J. M. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj062 · Cited by 254
Self-citationPeroxisome proliferator-activated receptor-α and liver cancer: where do we stand?
Peters, J. M., Cheung, C., & Gonzalez, F. J. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0678-9 · Cited by 248
Self-citationActivation of PPARβ/δ Induces Endothelial Cell Proliferation and Angiogenesis
Piqueras, L., Reynolds, A. R., Hodivala-Dilke, K. M., Alfranca, A., Redondo, J. M., Hatae, T., Tanabe, T., Warner, T. D., & Bishop-Bailey, D. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000250972.83623.61 · Cited by 246
Piccinni, C., Motola, D., Marchesini, G., & Poluzzi, E. (2011) · Diabetes Care · doi:10.2337/dc10-2412 · Cited by 239
Nagasawa, T., Inada, Y., Nakano, S., Tamura, T., Takahashi, T., Maruyama, K., Yamazaki, Y., Kuroda, J., & Shibata, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.028 · Cited by 233
Burstein, H. J., Demetri, G. D., Mueller, E., Sarraf, P., Spiegelman, B. M., & Winer, E. P. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1024038127156 · Cited by 228
Shiau, C.-W., Yang, C.-C., Kulp, S. K., Chen, K.-F., Chen, C.-S., Huang, J.-W., & Chen, C.-S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1677 · Cited by 222
Target Genes of Peroxisome Proliferator-activated Receptor γ in Colorectal Cancer Cells
Gupta, R. A., Brockman, J. A., Sarraf, P., Willson, T. M., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103779200 · Cited by 215
Cheung, C., Akiyama, T. E., Ward, J. M., Nicol, C. J., Feigenbaum, L., Vinson, C., & Gonzalez, F. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0322 · Cited by 215
Self-citationTranscriptional network governing the angiogenic switch in human pancreatic cancer
Abdollahi, A., Schwager, C., Kleeff, J., Esposito, I., Domhan, S., Peschke, P., Hauser, K., Hahnfeldt, P., Hlatky, L., Debus, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705505104 · Cited by 215
Self-citationPeroxisome proliferator–activated receptor-δ attenuates colon carcinogenesis
Harman, F. S., Nicol, C. J., Marin, H. E., Ward, J. M., Gonzalez, F. J., & Peters, J. M. (2004) · Nature Medicine · doi:10.1038/nm1026 · Cited by 213
Self-citationMotomura, W., Okumura, T., Takahashi, N., OBARA, T., & Kohgo, Y. (2000) · PubMed · doi:10.11501/3186319 · Cited by 209
Adachi, M., Kurotani, R., Morimura, K., Shah, Y., Sanford, M., Madison, B. B., Gumucio, D. L., Marin, H. E., Peters, J. M., Young, H. A., et al. (2006) · Gut · doi:10.1136/gut.2005.081745 · Cited by 209
Self-citationPPAR gamma and human metabolic disease
Chatterjee, K. (2006) · 8th European Congress of Endocrinology incorporating the British Endocrine Societies · Cited by 209
The peroxisome proliferator‐activated receptor α regulates amino acid metabolism
KERSTEN, S., MANDARD, S., ESCHER, P., GONZALEZ, F. J., TAFURI, S., DESVERGNE, B., & WAHLI, W. (2001) · The FASEB Journal · doi:10.1096/fj.01-0147com · Cited by 203
Self-citationSprecher, D. L., Massien, C., Pearce, G., Billin, A. N., Perlstein, I., Willson, T. M., Hassall, D. G., Ancellin, N., Patterson, S. D., Lobe, D. C., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000252790.70572.0c · Cited by 201
Endogenous Ligands for Nuclear Receptors: Digging Deeper
Schupp, M., & Lazar, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.182451 · Cited by 182
Wang, D., Wang, H., Guo, Y., Ning, W., Katkuri, S., Wahli, W., Desvergne, B., Dey, S. K., & DuBois, R. N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607948103 · Cited by 182
Stephen, R. L., Gustafsson, M. C. U., Jarvis, M., Tatoud, R., Marshall, B. R., Knight, D., Ehrenborg, E., Harris, A. L., Wolf, C. R., & Palmer, C. N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2760 · Cited by 181
PPARγ signaling exacerbates mammary gland tumor development
Saez, E., Rosenfeld, J., Livolsi, A., Olson, P., Lombardo, E., Nelson, M., Banayo, E., Cardiff, R. D., Izpisua-Belmonte, J. C., & Evans, R. M. (2004) · Genes & Development · doi:10.1101/gad.1167804 · Cited by 178
Koga, H., Sakisaka, S., Harada, M., Takagi, T., Hanada, S., Taniguchi, E., Kawaguchi, T., Sasatomi, K., Kimura, R., Hashimoto, O., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24024 · Cited by 175
Ogino, S., Shima, K., Baba, Y., Nosho, K., Irahara, N., Kure, S., Chen, L., Toyoda, S., Kirkner, G. J., Wang, Y. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.048 · Cited by 171
Insulin resistance and cancer: Epidemiological evidence
Tsugane, S., & Inoue, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01521.x · Cited by 169
Burdick, A. D., Kim, D. J., Peraza, M. A., Gonzalez, F. J., & Peters, J. M. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.07.009 · Cited by 168
Self-citationMorimura, K., Cheung, C., Ward, J. M., Reddy, J. K., & Gonzalez, F. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi329 · Cited by 168
Self-citationQin, C., Burghardt, R. C., Smith, R., Wormke, M., Stewart, J., & Safe, S. H. (2003) · PubMed · Cited by 167
Wang, C., Fu, M., D'Amico, M., Albanese, C., Zhou, J.-N., Brownlee, M., Lisanti, M. P., Chatterjee, V. K. K., Lazar, M. A., & Pestell, R. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3057-3070.2001 · Cited by 165
Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
Liu, S., Hatano, B., Zhao, M., Yen, C.-C., Kang, K., Reilly, S. M., Gangl, M. R., Görgün, C. Z., Balschi, J. A., Ntambi, J. M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.138115 · Cited by 163
A phase II trial with rosiglitazone in liposarcoma patients
Debrock, G., Vanhentenrijk, V, Sciot, R., Debiec-Rychter, M., Oyen, R., & Van Oosterom, A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601306 · Cited by 160
Kulke, M. H., Demetri, G. D., Sharpless, N. E., Ryan, D. P., Shivdasani, R. A., Clark, J. S., Spiegelman, B. M., Kim, H. T., Mayer, R. J., & Fuchs, C. S. (2002) · The Cancer Journal · doi:10.1097/00130404-200209000-00010 · Cited by 154
Giordano, T. J., Au, A. Y. M., Kuick, R. D., Thomas, D. G., Rhodes, D. R., Wilhelm, K. G., Vinco, M., Misek, D. E., Sanders, D., Zhu, Z., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2039 · Cited by 152
Girroir, E. E., Hollingshead, H. E., He, P., Zhu, B., Perdew, G. H., & Peters, J. M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.086 · Cited by 150
Self-citationPPARβ/δ selectively induces differentiation and inhibits cell proliferation
Kim, D. J., Bility, M. T., Billin, A. N., Willson, T. M., Gonzalez, F. J., & Peters, J. M. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401713 · Cited by 149
Self-citationNiho, N., Takahashi, M., Kitamura, T., Shoji, Y., Itoh, M., Noda, T., Sügimura, T., & Wakabayashi, K. (2003) · PubMed · Cited by 148
Insulin resistance and cancer: epidemiological evidence
Inoue, M., & Tsugane, S. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0142 · Cited by 147
Hisatake, J., Ikezoe, T., Carey, M., Holden, S. A., Tomoyasu, S., & Koeffler, H. P. (2000) · PubMed · Cited by 146
Shearer, B. G., Steger, D. J., Way, J. M., Stanley, T. B., Lobe, D. C., Grillot, D., Iannone, M. A., Lazar, M. A., Willson, T. M., & Billin, A. N. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0190 · Cited by 144
Lapillonne, H., Konopleva, M. Y., Tsao, T., Gold, D. L., McQueen, T. J., Sutherland, R. L., Madden, T. L., & Andreeff, M. (2003) · PubMed · Cited by 144
Troglitazone Inhibits Growth of MCF-7 Breast Carcinoma Cells by Targeting G1 Cell Cycle Regulators
Yin, F., Wakino, S., Liu, Z., Kim, S., Hsueh, W. A., Collins, A. R., Herle, A. J. V., & Law, R. E. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5491 · Cited by 143
Sharma, C., Pradeep, A., Wong, L., Rana, A., & Rana, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403143200 · Cited by 141
Ligand Activation of Peroxisome Proliferator–Activated Receptor β Inhibits Colon Carcinogenesis
Marin, H. E., Peraza, M. A., Billin, A. N., Willson, T. M., Ward, J. M., Kennett, M. J., Gonzalez, F. J., & Peters, J. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4277 · Cited by 140
Self-citationHuang, J., Shiau, C., Yang, Y.-T. C., Kulp, S. K., Chen, K., Brueggemeier, R. W., Shapiro, C. L., & Chen, C. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007732 · Cited by 139
Chen, L.-C., Hao, C., Chiu, Y. S. Y., Wong, P., Melnick, J., Brotman, M., Moretto, J. C., Mendes, F., Smith, A. P., Bennington, J. L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3264 · Cited by 137
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARγ
Zander, T., Kraus, J. A., Grommes, C., Schlegel, U. S., Feinstein, D. L., Klockgether, T., Landreth, G. E., Koenigsknecht-Talboo, J., & Heneka, M. T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00899.x · Cited by 136
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands
Kohno, H., Suzuki, R., Sugie, S., & Tanaka, T. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-46 · Cited by 136
Bae, M., & Song, B. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.401 · Cited by 133
Tachibana, K., Kobayashi, Y., Tanaka, T., Tagami, M., Sugiyama, A., Katayama, T., Ueda, C., Yamasaki, D., Ishimoto, K., Sumitomo, M., et al. (2005) · Nuclear Receptor · doi:10.1186/1478-1336-3-3 · Cited by 132
Tong, B. J., Tan, J., Tajeda, L., Das, S. K., Chapman, J. A., DuBois, R. N., & Dey, S. K. (2000) · Neoplasia · doi:10.1038/sj.neo.7900119 · Cited by 130
Hays, T., Rusyn, I., Burns, A., Kennett, M. J., Ward, J. M., Gonzalez, F. J., & Peters, J. M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh285 · Cited by 130
Self-citationPeters, J. M., Hollingshead, H. E., & Gonzalez, F. J. (2008) · Clinical Science · doi:10.1042/cs20080022 · Cited by 129
Self-citationSynergy between PPARγ Ligands and Platinum-Based Drugs in Cancer
Girnun, G. D., Naseri, E., Vafai, S. B., Qu, L., Szwaya, J. D., Bronson, R. T., Alberta, J. A., & Spiegelman, B. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.025 · Cited by 128
Smith, M. R., Manola, J. B., Kaufman, D. S., George, D. J., Oh, W. K., Mueller, E., Slovin, S. F., Spiegelman, B. M., Small, E. J., & Kantoff, P. W. (2004) · Cancer · doi:10.1002/cncr.20493 · Cited by 126
Schaefer, K. L., Wada, K., Takahashi, H., Matsuhashi, N., Ohnishi, S., Wolfe, M. M., Turner, J. R., Nakajima, A., Borkan, S. C., & Saubermann, L. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3037 · Cited by 126
Kebebew, E., Peng, M., Reiff, E. S., TRESELER, P. A., Woeber, K. A., Clark, O. H., Greenspan, F. S., Lindsay, S., Duh, Q., & Morita, E. (2006) · Surgery · doi:10.1016/j.surg.2006.07.038 · Cited by 125
Shah, Y. M., Morimura, K., & Gonzalez, F. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00381.2006 · Cited by 121
Self-citationIncreased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and Rosiglitazone
Teresi, R. E., Shaiu, C., Chen, C., Chatterjee, K., Waite, K. A., & Eng, C. (2006) · International Journal of Cancer · doi:10.1002/ijc.21799 · Cited by 120
PPARγ-independent antitumor effects of thiazolidinediones
Wei, S., Yang, J., Lee, S.-L., Kulp, S. K., & Chen, C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.008 · Cited by 119
Orner, G. A. (2003) · Carcinogenesis · doi:10.1093/carcin/24.2.263 · Cited by 118
Biscetti, F., Gaetani, E., Flex, A., Aprahamian, T. R., Hopkins, T. A., Straface, G., Pecorini, G., Stigliano, E., Smith, R. C., Angelini, F., et al. (2008) · Diabetes · doi:10.2337/db07-0765 · Cited by 115
PPARδ status and Apc-mediated tumourigenesis in the mouse intestine
Reed, K. R., Sansom, O. J., Hayes, A. J., Gescher, A. J., Winton, D. J., Peters, J. M., & Clarke, A. R. (2004) · Oncogene · doi:10.1038/sj.onc.1208143 · Cited by 113
Self-citationFauconnet, S., Lascombe, I., Chabannes, É., Adessi, G., Desvergne, B., Wahli, W., & Bittard, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200172200 · Cited by 109
Pozzi, A., Ibáñez, M. R., Gatica, A., Yang, S., Wei, S. D., Mei, S., Falck, J. R., & Capdevila, J. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701429200 · Cited by 109
Activation of PPARγ increases PTEN expression in pancreatic cancer cells
Farrow, B. J., & Evers, B. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02983-2 · Cited by 107
Yoshizumi, T., Ohta, T., Ninomiya, I., Terada, I., Fushida, S., Fujimura, T., Nishimura, G., Shimizu, K., Yi, S., & Miwa, K. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.3.631 · Cited by 107
Yoshimura, R., Matsuyama, M., Segawa, Y., Hase, T., Mitsuhashi, M., Tsuchida, K., Wada, S., Kawahito, Y., Sano, H., & Nakatani, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.10980 · Cited by 104
Feilchenfeldt, J. W., Bründler, M., Soravia, C., Tötsch, M., & Meier, C. A. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.08.024 · Cited by 104
Kim, D. J., Akiyama, T. E., Harman, F. S., Burns, A., Shan, W., Ward, J. M., Kennett, M. J., Gonzalez, F. J., & Peters, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312063200 · Cited by 104
Self-citationHic-5 regulates an epithelial program mediated by PPARγPreprint
Drori, S., Girnun, G. D., Tou, L., Szwaya, J. D., Mueller, E., Kia, X., Shivdasani, R. A., & Spiegelman, B. M. (2005) · Genes & Development · doi:10.1101/gad.1240705 · Cited by 103
Modica, S., Gofflot, F., Murzilli, S., D’Orazio, A., Salvatore, L., Pellegrini, F., Nicolucci, A., Tognoni, G., Copetti, M., Valanzano, R., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.060 · Cited by 102
Peters, J. M., & Gonzalez, F. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.06.002 · Cited by 102
Self-citationPPARβ/δ potentiates PPARγ‐stimulated adipocyte differentiation
Matsusue, K., Peters, J. M., & Gonzalez, F. J. (2004) · The FASEB Journal · doi:10.1096/fj.04-1944fje · Cited by 101
Self-citationCrowe, D. L., & Chandraratna, R. A. S. (2004) · Breast Cancer Research · doi:10.1186/bcr913 · Cited by 101
Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ‐deficient mice
Müller‐Brüsselbach, S., Kömhoff, M., Rieck, M., Meißner, W., Kaddatz, K., Adamkiewicz, J., Keil, B. R., KLOSE, K. J., Moll, R., Burdick, A. D., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601803 · Cited by 101
Self-citationBezafibrate is a dual ligand for PPARα and PPARβ: studies using null mice
Peters, J. M., Aoyama, T., Burns, A., & Gonzalez, F. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(03)00065-9 · Cited by 100
Self-citationYamazaki, K., Shimizu, M., Okuno, M., Matsushima‐Nishiwaki, R., Kanemura, N., Araki, H., Tsurumi, H., Kojima, S., Weinstein, I. B., & Moriwaki, H. (2007) · Gut · doi:10.1136/gut.2007.129858 · Cited by 99
PPAR-γ agonist increase gefitinib's antitumor activity through PTEN expression
Lee, S. Y., Hur, G. Y., Jung, K. H., Jung, H. C., Lee, S. Y., Kim, J. H., Shin, C., Shim, J. J., In, K. H., Kang, K. H., et al. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.10.010 · Cited by 98
Shan, W., Palkar, P. S., Murray, I. A., McDevitt, E. I., Kennett, M. J., Kang, B. H., Isom, H. C., Perdew, G. H., Gonzalez, F. J., & Peters, J. M. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn142 · Cited by 97
Self-citationShan, W., Nicol, C. J. B., Ito, S., Bility, M. T., Kennett, M. J., Ward, J. M., Gonzalez, F. J., & Peters, J. M. (2007) · Hepatology · doi:10.1002/hep.21925 · Cited by 94
Self-citationPPAR-γ agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts
Chintalgattu, V., HARRIS, G., Akula, S. M., & Katwa, L. C. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.010 · Cited by 94
Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer
Fenner, M. H., & Elstner, E. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.557 · Cited by 88
Intestinal‐specific PPARγ deficiency enhances tumorigenesis in ApcMin/+ mice
McAlpine, C. A., Barak, Y., Matise, I., & Cormier, R. T. (2006) · International Journal of Cancer · doi:10.1002/ijc.22115 · Cited by 88
PPARbeta/delta ligands as modulators of the inflammatory response.
Kilgore, K. S., & Billin, A. N. (2008) · PubMed · Cited by 87
Chu, K., Lee, S., Koo, J.-S., Jung, K., Kim, E., Sinn, D.-I., Kim, J., Ko, S., Kim, S., Song, E.-C., et al. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.114 · Cited by 87
Burdick, A. D., Bility, M. T., Girroir, E. E., Billin, A. N., Willson, T. M., Gonzalez, F. J., & Peters, J. M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.007 · Cited by 83
Self-citationZuo, X., Peng, Z., Moussalli, M. J., Morris, J. S., Broaddus, R. R., Fischer, S. M., & Shureiqi, I. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp078 · Cited by 82
Differentiation and growth inhibition mediated via the RXR:PPARγ heterodimer in colon cancer
Cesario, R. M., Stone, J. K., Yen, W.-C., et al. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.09.010 · Cited by 81
Zhang, Q., Zhou, H., Zhai, S., & Yan, B. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791208983 · Cited by 81
Shearer, B. G., Wiethe, R. W., Ashe, A., Billin, A. N., Way, J. M., Stanley, T. B., Wagner, C. D., Xu, R. X., Leesnitzer, L. M., Merrihew, R. V., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900464j · Cited by 78
Adhikary, T., Kaddatz, K., Finkernagel, F., Schönbauer, A., Meißner, W., Scharfe, M., Jarek, M., Blöcker, H., Müller‐Brüsselbach, S., & Müller, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016344 · Cited by 78
Jaeckel, E., Raja, S., Tan, J., Das, S. K., Dey, S. K., Girod, D. A., Tsue, T. T., & Sanford, T. R. (2001) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.127.10.1253 · Cited by 78
Széles, L., Póliska, S., Nagy, G., Szatmári, I., Szántó, A., Pap, A., Lindstedt, M., Santegoets, S. J. A. M., Rühl, R., Dezsö, B., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0215 · Cited by 77
Lubet, R. A., Fischer, S. M., Steele, V. E., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23765 · Cited by 77
Tepmongkol, S., Keelawat, S., Honsawek, S., & Ruangvejvorachai, P. (2008) · Thyroid · doi:10.1089/thy.2008.0056 · Cited by 76
Khanim, F. L., Hayden, R. E., Birtwistle, J., Lodi, A., Tiziani, S., Davies, N., Ride, J. P., Viant, M. R., Günther, U. L., Mountford, J. C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008147 · Cited by 76
Huang, P., Sata, M., Nishimatsu, H., Sumi, M., Hirata, Y., & Nagai, R. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.06.014 · Cited by 76
Hollingshead, H. E., Killins, R. L., Borland, M. G., Girroir, E. E., Billin, A. N., Willson, T. M., Sharma, A. K., Amin, S., Gonzalez, F. J., & Peters, J. M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm183 · Cited by 74
Self-citationYang, K., Fan, K., Lamprecht, S. A., Edelmann, W., Kopelovich, L., Kucherlapati, R., & Lipkin, M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21018 · Cited by 73
Elnemr, A., Ohta, T., Iwata, K., et al. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.6.1157 · Cited by 73
Schultze, K., Böck, B. C., Eckert, A., Oevermann, L., Ramacher, D., Wiestler, O. D., & Roth, W. (2006) · APOPTOSIS · doi:10.1007/s10495-006-8896-3 · Cited by 72
Itami, A., Watanabe, G., Shimada, Y., Hashimoto, Y., Kawamura, J., Kato, M., Hosotani, R., & Imamura, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1488 · Cited by 71
Burton, J. D., Goldenberg, D. M., & Blumenthal, R. D. (2008) · PPAR Research · doi:10.1155/2008/494161 · Cited by 71
Hau, P., Kunz‐Schughart, L. A., Bogdahn, U., Baumgart, U., Hirschmann, B., Weimann, E., Mühleisen, H., Ruemmele, P., Steinbrecher, A., & Reichle, A. (2007) · Oncology · doi:10.1159/000120028 · Cited by 70
Takayama, O., Yamamoto, H., Damdinsuren, B., Sugita, Y., Ngan, C. Y., Xu, X., Tsujino, T., Takemasa, I., Ikeda, M., Sekimoto, M., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603343 · Cited by 69
Koga, H., Harada, M., Ohtsubo, M., Shishido, S., Kumemura, H., Hanada, S., Taniguchi, E., Yamashita, K., Kumashiro, R., Ueno, T., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50186 · Cited by 69
(2004) · PubMed · Cited by 69
Differential Gene Regulation by PPARγ Agonist and Constitutively Active PPARγ2
Li, Y., & Lazar, M. A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0825 · Cited by 66
Peters, J. M., Foreman, J. E., & Gonzalez, F. J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9320-1 · Cited by 64
Self-citationPalkar, P. S., Borland, M. G., Naruhn, S., Ferry, C. H., Lee, C. Y., Sk, U. H., Sharma, A. K., Amin, S., Murray, I. A., Anderson, C. R., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065508 · Cited by 64
Self-citationAbbott, B. D., Wood, C. R., Watkins, A. M., Das, K. P., & Lau, C. S. (2010) · PPAR Research · doi:10.1155/2010/690907 · Cited by 64
Zhang, W., & Wu, N. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.8.2887 · Cited by 63
Borland, M. G., Foreman, J. E., Girroir, E. E., Zolfaghari, R., Sharma, A. K., Amin, S., Gonzalez, F. J., Ross, A. C., & Peters, J. M. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050609 · Cited by 62
Self-citationHollingshead, H. E., Borland, M. G., Billin, A. N., Willson, T. M., Gonzalez, F. J., & Peters, J. M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm209 · Cited by 61
Self-citationStill, K., Grabowski, P., Mackie, I. P., Perry, M., & Bishop, N. J. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9175-9 · Cited by 60
Ouyang, N., Williams, J. L., & Rigas, B. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi221 · Cited by 60
Wei, S., Lin, L.-F., Yang, C.-C., Wang, Y.-C., Chang, G.-D., Chen, H., & Chen, C. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035287 · Cited by 59
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer
Jackson, L., Wahli, W., Michalik, L., Watson, S. A., Morris, T., Anderton, K., Bell, D. R., Smith, J. A., Hawkey, C. J., & Bennett, A. J. (2003) · Gut · doi:10.1136/gut.52.9.1317 · Cited by 57
Transcriptional Network Governing the Angiogenic Switch in Human Pancreatic Cancer
Abdollahi, A., Schwager, C., Kleeff, J. H., et al. (2008) · Topologica · doi:10.3731/topologica.1.016 · Cited by 55
Chen, F., & Harrison, L. E. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.11.002 · Cited by 50
Reddy, R. C., Srirangam, A., Reddy, K., Chen, J., Gangireddy, S. R., Kalemkerian, G. P., Standiford, T. J., & Keshamouni, V. G. (2008) · Neoplasia · doi:10.1593/neo.08134 · Cited by 49
YAN, K.-H., Yao, C., Chang, H., Lai, G., Cheng, A., & Chuang, S. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20593 · Cited by 48
Yang, L., Zhang, H., Zhou, Z., Yan, H., Adell, G., & Sun, X. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2779 · Cited by 47
Yokoyama, Y., Xin, B., Shigeto, T., & Mizunuma, H. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-0993-1 · Cited by 45
Pollock, C. B., Yin, Y., Yuan, H., Zeng, X., King, S., Li, X., Kopelovich, L., Albanese, C., & Glazer, R. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016215 · Cited by 44
Differential Gene Regulation by PPAR Agonist and Constitutively Active PPAR 2
Li, Y. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.1040 · Cited by 44
Peroxisome proliferator‐activated receptors in squamous cell carcinoma and its precursors
Nijsten, T. E. C., Geluyckens, E., Colpaert, C., & Lambert, J. R. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2005.00345.x · Cited by 43
Foreman, J. E., Chang, W., Palkar, P. S., Zhu, B., Borland, M. G., Williams, J. L., Kramer, L. R., Clapper, M. L., Gonzalez, F. J., & Peters, J. M. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20757 · Cited by 43
Self-citationBility, M. T., Devlin-Durante, M. K., Blazanin, N., Glick, A. B., Ward, J. M., Kang, B. H., Kennett, M. J., Gonzalez, F. J., & Peters, J. M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn219 · Cited by 42
Self-citationNaruhn, S., Toth, P. M., Adhikary, T., Kaddatz, K., Pape, V. F. S., Dörr, S., Klebe, G., Müller‐Brüsselbach, S., Diederich, W. E., & Müller, R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.074039 · Cited by 42
Yoshinaga, M., Taki, K., Somada, S., Sakiyama, Y., Kubo, N., Kaku, T., Tsuruta, S., Kusumoto, T., Sakai, H., Nakamura, K., et al. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1389-9 · Cited by 41
Thiazolidinediones and Cardiovascular Risk — A Question of Balance
Erdmann, E., Charbonnel, B. H., & Wilcox, R. (2009) · Current Cardiology Reviews · doi:10.2174/157340309788970333 · Cited by 40
Thiazolidinedione Therapy Gets Complicated
Schwartz, A. V., & Sellmeyer, D. E. (2007) · Diabetes Care · doi:10.2337/dc07-0554 · Cited by 38
Foreman, J. E., Sorg, J. M., McGinnis, K. S., Rigas, B., Williams, J. L., Clapper, M. L., Gonzalez, F. J., & Peters, J. M. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20546 · Cited by 37
Self-citationHayden, R. E., Pratt, G., Davies, N., Khanim, F. L., Birtwistle, J., Delgado, J., Pearce, C., Sant, T. M., Drayson, M. T., & Bunce, C. M. (2008) · Leukemia · doi:10.1038/leu.2008.283 · Cited by 37
Wang, D., Ning, W., Xie, D., Guo, L., & DuBois, R. N. (2011) · Oncogene · doi:10.1038/onc.2011.299 · Cited by 35
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Serine and one-carbon metabolism in cancer
Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992
High-fat diet enhances stemness and tumorigenicity of intestinal progenitors
Beyaz, S., Mana, M. D., Roper, J., Kedrin, D., Saadatpour, A., Hong, S.-J., Bauer-Rowe, K. E., Xifaras, M. E., Akkad, A., Arias, E., et al. (2016) · Nature · doi:10.1038/nature17173 · Cited by 845
Mirza, A. Z., Althagafi, I. I., & Shamshad, H. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.067 · Cited by 544
Brase, R. A., Mullin, E. J., & Spink, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22030995 · Cited by 374
Metadata
- Authors
- Peters, J. M., Shah, Y. M., & Gonzalez, F. J.
- Venue
- Nature Reviews Cancer
- Published
- 2012-02-09
- Volume
- 12
- Issue
- 3
- Pages
- 181-195
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2034131665
- Cited by
- 492
- References
- 225
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.